Prospective Evaluation of Blunt Renal Injury in Children
NCT ID: NCT00855036
Last Updated: 2025-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
100 participants
OBSERVATIONAL
2008-08-31
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Severe Sepsis in Children - IMPRESS-C
NCT02598674
Pediatric Blunt Abdominal Trauma Clinical Prediction Model
NCT02206698
Acute Kidney Injury in Children Operated for Congenital Heart Disease
NCT01316497
Long Term Impact of Pediatric Acute Renal Injury in Severe Sepsis
NCT02372721
Management of Grades 3-5 Renal Trauma in Pediatrics
NCT04572204
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the retrospective data, we found one patient developed intermittent hypertension. However, identifying this one patient requires that the hypertension is documented in our medical record, which means we may miss those patients managed by their pediatricians. More concerning is that we may be missing patients who have hypertension. These potential patients may get well into adulthood before the hypertension is detected which is why this study is imperative to define the natural history of renal healing, quantify the risk of hypertension, and potentially identify predictors of this complication.
The management protocol currently being followed and proposed for this study will include one night of bedrest and then the patient may be ambulatory the next day. From this point, patients will be managed in the hospital until they meet general discharge criteria. Discharge criteria are adequate pain control with oral pain medications and tolerating regular diet.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Renal Injury
All patients who have a discernable injury to the renal parenchyma on CT scan from blunt trauma
Attenuated bedrest
Patients are allowed to ambulate the morning after admission and then can be discharged when eating well and pain is controlled on oral pain medication regardless of hematuria
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Attenuated bedrest
Patients are allowed to ambulate the morning after admission and then can be discharged when eating well and pain is controlled on oral pain medication regardless of hematuria
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Less than 18 years of age at time of injury
* Patients without known bleeding abnormalities
Exclusion Criteria
* Children with known bleeding abnormalities
* Patients 18 years of age and older at the time of injury
* Inability to comply with the intended follow up
* Patients with open/penetrating renal trauma
1 Month
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Phoenix Children's Hospital
OTHER
Children's Mercy Hospital Kansas City
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shawn St. Peter
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shawn D St. Peter, MD
Role: PRINCIPAL_INVESTIGATOR
Children's Mercy Hospital Kansas City
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Mercy Hospital
Kansas City, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11120119
Identifier Type: OTHER
Identifier Source: secondary_id
STUDY00003106
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.